YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.

de Nigris, Filomena; Zanella, Licciana; Cacciatore, Francesco; De Chiara, Anna; Fazioli, Flavio; Chiappetta, Gennaro; Apice, Gaetano; Infante, Teresa; Monaco, Mario; Rossiello, Raffaele; De Rosa, Gaetano; Alberghini, Marco; Napoli, Claudio

de Nigris, Filomena; Zanella, Licciana; Cacciatore, Francesco; De Chiara, Anna; Fazioli, Flavio; Chiappetta, Gennaro; Apice, Gaetano; Infante, Teresa; Monaco, Mario; Rossiello, Raffaele; De Rosa, Gaetano; Alberghini, Marco; Napoli, Claudio.

Affiliation

de Nigris F; Department of General Pathology, Division of Clinical Pathology and U.O.C. Immunohematology, Second University of Naples, 80138 Naples, Italy. filomena.denigris@unina2.it

BMC Cancer ; 11: 472, 2011 Nov 02.

Article in En | MEDLINE | ID: mdl-22047406

Subject(s)

Bone Neoplasms/metabolism; Neoplasm Proteins/metabolism; Osteosarcoma/metabolism; YY1 Transcription Factor/metabolism; Adult; Analysis of Variance; Bone Neoplasms/therapy; Disease-Free Survival; Female; Humans; Immunohistochemistry; Male; Middle Aged; Multivariate Analysis; Osteosarcoma/secondary; Osteosarcoma/therapy; Prognosis; Prospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma / YY1 Transcription Factor / Neoplasm Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2011 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google